Ricerca di contatti, progetti,
corsi e pubblicazioni

ATAC - Antibody therapy against coronavirus (COVID-2019)

Persone

 

Varani L.

(Responsabile)

Robbiani D.

(Co-responsabile)

Abstract

Passive immunotherapy, through the transfer of antibodies, has been proposed as a potential approach for treating patients with COVID-19. Building on previous experience of antibody therapy against SARS- and MERS-CoV, scientists of the EU-funded ATAC project will characterise human antibodies obtained from the blood of recovered coronavirus patients from China and Italy. Using a combination of experimental and computational work, they will optimise, produce and test all antibodies before selecting the most effective candidate for therapy. The rapid dissemination of the project's results will help the medical community respond to the current COVID-19 pandemic through improved patient management.

Informazioni aggiuntive

Acronimo
ATAC
Data d'inizio
01.04.2020
Data di fine
31.03.2022
Durata
24 Mesi
Enti finanziatori
Stato
In corso
Categoria
European and International Programmes / Horizon 2020 / Collaborative projects - Societal Challenges